These findings not only support dominant but complicated roles of immunity in host defense and tumor pathogenesis, but also provide a molecular and cellular basis to target myeloid NF-κB2 to restore antitumor immunity for lung cancer prevention and treatment. Here, NFKB2 is linked to neoplasm.